China urges companies to ensure COVID-related medical supplies
BEIJING, Dec 15 (Reuters) - China has urged state-backed
pharmaceuticals giants to ensure provision of COVID-related
medical supplies, the country's state asset regulator said on
Thursday.
The companies include China Resources, China General
Technology and Sinopharm, which own businesses that produce
medications that could ease coronavirus symptoms.
(Reporting by Ella Cao and Meg Shen
Editing by David Goodman)
((Ella.Cao@thomsonreuters.com;))
Recent news on China Resources Medical Holdings
See all newsBrief: China Resources Medical Receives Original Judgment On August 26
Brief: China Resources Medical Appoints Yu Changjiu As Chief Financial Officer
Brief: China Resources Medical Sees H1 2026 Profit Attributable Rmb252 Million-Rmb278 Million
Brief: China Resources Medical Terminates Hospital Iot Agreements Effective July 1, 2026
Brief: China Resources Medical To Pay Final Dividend Of RMB8.4 Cents Per Share